Onconova Therapeutics Inc ONTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/22/21 EDT
6.99quote price arrow up+6.99 (UNCH)
Volume
6,906
Close
6.97quote price arrow up+0.14 (+2.05%)
Volume
407,477
52 week range
2.85 - 28.95

...

Loading . . .
  • Open6.71
  • Day High6.98
  • Day Low6.63
  • Prev Close6.97
  • 52 Week High28.95
  • 52 Week High Date02/18/21
  • 52 Week Low2.85
  • 52 Week Low Date09/04/20

Key Stats

  • Market Cap109.99M
  • Shares Out15.78M
  • 10 Day Average Volume1.13M
  • Dividend-
  • Dividend Yield-
  • Beta1.69
  • YTD % Change-0.24

KEY STATS

  • Open6.71
  • Day High6.98
  • Day Low6.63
  • Prev Close6.97
  • 52 Week High28.95
  • 52 Week High Date02/18/21
  • 52 Week Low2.85
  • 52 Week Low Date09/04/20
  • Market Cap109.99M
  • Shares Out15.78M
  • 10 Day Average Volume1.13M
  • Dividend-
  • Dividend Yield-
  • Beta1.69
  • YTD % Change-0.24

RATIOS/PROFITABILITY

  • EPS (TTM)-2.01
  • P/E (TTM)-3.46
  • Fwd P/E (NTM)-8.01
  • EBITDA (MRQ)-23.953M
  • ROE (MRQ)-84.72%
  • Revenue (MRQ)240,000.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-10,544.68%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/10/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Onconova Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells. It has over three clinical-stage product candidates and various...
James Marino J.D.
Chairman
Steven Fruchtman M.D.
President
Mark Guerin
Chief Financial Officer
Abraham Oler
Vice President
Address
375 Pheasant Run
Newtown, PA
18940-3423
United States

Top Peers

SYMBOLLASTCHG%CHG
OTIC
Otonomy Inc
2.18-0.05-2.24%
RZLT
Rezolute Inc
12.52+0.07+0.56%
LYRA
Lyra Therapeutics Inc
8.08-0.24-2.88%
TCON
TRACON Pharmaceuticals Inc
6.38-0.29-4.35%
ALRN
Aileron Therapeutics Inc
1.23+0.01+0.82%